DISCUSSION FORUMS BLADDER CANCER WALK
  • English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • ABOUT US
    • Our Mission/Vision
    • Board Of Directors
    • Medical Advisory
      and Research Board
    • Sponsors & Partners
    • Financial Statements
    • Contact Us
  • FACING
    BLADDER CANCER
    • Newly Diagnosed?
    • Canadian Patient Guidebooks
    • Dealing With Emotions
    • Get Support
    • Join a Discussion Forum
    • Videos
    • Webinar Recordings
    • Patient Resources
  • HELPFUL
    INFORMATION
    • Bladder Cancer Facts
    • See Red?
    • Symptoms
    • Bladder Cancer Basics
      • How The Body Works
      • Types of Bladder Cancer
      • Causes
      • Diagnosis
      • Staging and Grading
    • How will my cancer be treated?
      • Nonmuscle Invasive
      • Muscle Invasive
      • Bladder Preservation
      • Metastatic Bladder Cancer
    • Bladder Removal
      • Diversion Types
      • Common Issues
      • Chemotherapy
      • After Your Surgery
      • At Home
    • Upper Tract Urothelial Carcinoma
    • Palliative Care
    • Doctor Resources
    • Glossary
    • Links
  • STORIES,
    NEWS & EVENTS
    • Latest News & Stories
    • Upcoming Meetings And Events
    • Newsletter Archive
  • RESEARCH and
    CLINICAL TRIALS
    • Canadian Bladder Cancer Information System
    • Clinical Trials
    • BCC Funded Research
    • BCC Research Grant
  • GET
    INVOLVED
    • BC Awareness Month & 10-yr Anniversary
    • Volunteer
    • Join An Awareness Walk
    • Host A Fundraiser
    • Subscribe To Our Newsletter
  • DONATE NOW
    • General Donations
    • Honour & Memorial Donations
    • Join an Awareness Walk
    • Planned Giving
    • Employer Matching Gifts
    • Donate a Vehicle
    • Where Your Donations Go
NextPrevious

Bladder cancer & COVID-19 FAQ

By Tawny Barratt | Latest news and stories | Comments are Closed | 26 March, 2020 | 5

Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way about how the this virus might affect their health and treatments.  We will be answering many of these questions  after consulting with the members of our Medical Advisory Boards. Please keep in mind that circumstances around this issue vary from region to region, and are changing by the hour, so some information may be rather general in nature. You may also wish to check out the Bladder Cancer Advocacy Network’s (BCAN) FAQ page here for further questions and answers.

As always, all of us here at BCC wish to support our community as best we can, but it’s important to emphasize that BCC staff are not medical professionals. It’s important to first turn to your medical team for advice, when possible.

Have a question? Send us an email at info@bladdercancercanada.org and we’ll do our best to answer it.

Can I receive the COVID-19 vaccine while having BCG treatments? If not, is there a waiting period before I can receive the vaccine?

There should be no hesitation to provide the COVID-19 vaccine to patients with non-muscle invasive bladder cancer. However, we have no direct evidence to guide us on the optimal timing of COVID-19 vaccination in patients receiving intravesical BCG. There are two important questions to consider: (1) is it safe to give the vaccine while being treated, and (2) will the vaccine be effective if administered during treatment.

Safety: BCG was originally developed as a vaccine, and its use in the bladder has some parallels to a regular vaccine. Both BCG and the COVID19 vaccines cause an inflammatory reaction. The National Advisory Committee on Immunization (NACI) makes broad recommendations guiding the timing of other vaccines relative to the COVID19 vaccines that is based on the time to achieve an optimal antibody response, but this is not relevant in the context of BCG therapy. Furthermore, in bladder cancer patients BCG is used to treat the cancer, and delays in BCG treatment due to vaccination could in fact harm patients. At the same time there is a risk of harm to patients if the vaccine is withheld longer than necessary.

Based on what we know about the mechanisms of the COVID-19 vaccines and how BCG works, we suggest that patients should have at least one week off BCG on each side of the vaccine (but ideally 2 weeks). This is easily achieved in patients receiving maintenance BCG where we think treatment can be delayed by a short time without negative effects. However, it may be more important that patients receiving induction BCG do not experience a delay before or during treatment. In these patients it is reasonable for patients to have 48 hours off BCG before and after the COVID-19 vaccine. If a patient has the opportunity to receive the COVID-19 vaccination before starting induction BCG it would be reasonable to wait one week after vaccination to start the BCG, and then administer the 2nd dose of the vaccine one week after the last dose of BCG.

This suggested approach is based on expert opinion after consultation with doctors specializing in infectious diseases and NACI. Ultimately patients should discuss BCG and COVID-19 vaccination with their treating physician so that treatment and vaccination timelines can be adjusted, and any symptoms can be managed should they occur.

Efficacy: BCG is an immune stimulator, and there is some evidence that it may improve the efficacy of vaccines. Therefore, there is no current concern that BCG treatment will detract from the efficacy of the vaccine.

You may also be interested in watching the following informative presentation “COVID19 in 2021: Focus on Vaccine in Bladder Cancer Patients” by Dr. Peter Black, Chair of our Medical Advisory and Research Boards, which was presented during a  recent B.C. support group meeting via Zoom.

I heard there is a study underway where BCG is being used to protect against COVID-19. Does that mean that my BCG treatments are protective against COVID?

There are several studies being conducted around the world investigating the use of the BCG vaccination (in the skin, not the bladder) to protect against COVID19 infection. Several epidemiological studies have investigated the risk of COVID19 infection in different populations that have or have not received the BCG vaccination. Since, these studies have come to conflicting conclusions, we do not know if prior BCG vaccination is protective. Furthermore, there is currently no direct evidence to indicate that intravesical (in the bladder) BCG therapy is protective. It might be, but in the meantime, patients need to observe all the recommended public health measures and seek vaccination when eligible.

It is important to note that both vaccines currently available in Canada (Moderna and Pfizer) are mRNA vaccines that do not pose a risk to patients with a suppressed immune system. The only uncertainty of administering the vaccines to patients with a suppressed immune system is that these patients might not be able to mount an adequate immune response after vaccination, so that the vaccine might be ineffective.

Will my next round of BCG treatments be delayed beyond the normal 3-4 month interval?

We have been advised by our Medical Advisory Board that at many centres, BCG maintenance treatments have been cancelled for the time being due to the COVID-19 crisis. However, your health care team would really be best able to answer your questions as they are familiar with your case and what care they are planning to provide.

                   

Does receiving treatment for non-muscle invasive bladder cancer increase my risk of getting COVID-19?

The diagnosis of patients and their required treatment can be very different. According to our Medical Advisory Board, it needs to be clear that none of the treatments for non-muscle invasive bladder cancer (NMIBC) affect the risk of getting COVID-19,  except through the exposure of being in the health care facility setting.  Some doctors think they can safely delay treatments for 3 months and they may consider this as an option to avoid the patient visits required for treatment. Treatment for NMIBC should not make the course of COVID19 more severe.

As always, it’s best to consult your health care team when you have questions and are feeling concerned, anxious or unsure.

                   

Will the treatment of my bladder cancer be affected by COVID-19?

It’s always best to consult your health care team with questions like these.

Your concerns and your wellbeing are a high priority of your attending doctors, nurses and other health care professionals but these times are unprecedented and you will need to heed their recommendations and follow their directives. In many cases, the most critical patients will receive treatments in priority. Some attending urologists have deferred 6 and 12 month bladder cancer cystoscopies as an example and may be cutting back on seeing new patients because their facility’s OR time is being reduced. In other cases (ie. metastatic bladder cancer), doctors will continue with the recommended treatment plan as they have a relatively narrow window of treatability. Since the COVID-19 situation is fluid and changing daily, each hospital and health care system may need to restrict access to therapies further depending on the local level of infection.

                   

Will receiving chemotherapy affect my immune system’s ability to fight COVID-19?

Chemotherapy treatment does affect your body’s immune system and all patients currently receiving treatment (or have received treatment in the past few months) should take care to isolate themselves from the increased risk of becoming affected by all viral and bacterial infections. Read our article Protecting Yourself During the Coronavirus for some helpful tips on how to protect yourself.

                   

What to do if I see blood in my urine during these exceptional circumstances? Is it still urgent to do a follow-up with a doctor?

It’s important to remember that blood in the urine can be a symptom of many conditions, some critical and some not. There are also a number of other important considerations such as if you have previously been diagnosed with bladder cancer or recently had a TURBT or BCG treatment. These are all important criteria in determining the seriousness of blood in the urine.

Diagnosis should be sought in in accordance to current healthcare priorities and protocols at healthcare facilities. If you were previously diagnosed with bladder cancer, it’s important to reach out to your health care team by phone for advice. If this is the first time you are seeing blood in your urine, a reasonable place to start is with a call to your family physician for further instructions.

                   

The medical supply chain is currently under great pressure. Will this impact my ability to order ostomy supplies?

We know that there are many patients that are ordering extra supplies to ensure that they are not stuck without supplies if the global situation does not improve soon. Other patients are ordering their usual quantities, in an effort to not contribute to depleting the supply that is needed for others. This is a personal decision and we do not feel strongly that one option is more appropriate than the other. We do know that some suppliers have indicated that delivery may be delayed due to the higher than normal order volume. You may want to keep this in mind when placing your order.

                   

I do not currently have a family physician to turn to. I am afraid of going to the walk in clinic or emergency, due to the COVID-19 situation and the potential risk to my general health. Where do I go?

Many doctor’s offices have turned to meeting with patients via Telehealth.

There are also a number of public Telehealth options available. Information about provincial services are included below:
British Columbia: https://www.healthlinkbc.ca/services-and-resources/about-8-1-1

Alberta: https://www.albertahealthservices.ca/maz/telehealth.aspx

Saskatchewan: https://www.ehealthsask.ca/services/telehealth

Manitoba: https://mb.211.ca/agencies/mb-telehealth/

Ontario:   https://www.ontario.ca/page/get-medical-advice-telehealth-ontario

Quebec: https://www.quebec.ca/en/health/finding-a-resource/info-sante-811/

New Brunswick: https://www2.gnb.ca/content/gnb/en/departments/health/Tele-Care.html

Nova Scotia: http://www.nshealth.ca/virtual-care

Prince Edward Island: https://www.princeedwardisland.ca/en/information/health-and-wellness/811-telehealth

Newfoundland and Labrador: https://www.811healthline.ca/

Nunuvut: https://www.gov.nu.ca/health/information/telehealth

North West Territories: https://www.hss.gov.nt.ca/en/services/nwt-healthnet/telehealth

Yukon: https://ykhealthguide.org/

Canadian Women’s Health Network has a source for telemedicine at this link:
http://www.cwhn.ca/en/yourhealth/provincialhealthlines

No tags.

Related Post

  • Bladder Cancer Canada (BCC) is seeking an Executive Director for our national charity.

    By Tawny Barratt | 0 comment

    Bladder Cancer Canada (BCC) is seeking an Executive Director for our national charity. Leading with a passion for BCC’s mission and vision that motivates and engages others, the new Executive Director will take our nearRead more

  • Congratulations to Dr. Michael A.S. Jewett for his appointment to the Order of Canada

    By Tawny Barratt | 0 comment

    Bladder Cancer Canada (BCC) is thrilled to congratulate Dr. Michael A.S. Jewett, Professor of Surgery (Urology) at the Princess Margaret Cancer Centre and at the University of Toronto, for his appointment to the Order of Canada,Read more

  • Cathy, a bladder cancer patient, is experiencing the impacts of COVID in a unique way

    By Tawny Barratt | Comments are Closed

    Wearing a mask in public spaces during COVID has been a challenge for so many of us. But for Cathy, who reads lips to communicate with others, it’s muted the world around her. Cathy, whoRead more

  • Message from the BCC Chair regarding COVID-19 – We are here for you.

    By Tawny Barratt | Comments are Closed

    Dearest Friend, Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that’s affecting us all on some level. For those of you diagnosed with bladder cancer, undergoing treatment,Read more

  • Have your say – patient and caregiver survey!

    By Tawny Barratt | Comments are Closed

    Dear Friend of Bladder Cancer Canada,Please help us understand what patients and caregivers think is important in bladder cancer research.Below is a link to a patient and caregiver survey that has been designed by our colleagues atRead more

  • Protecting Yourself During the Coronavirus Outbreak

    By Tawny Barratt | Comments are Closed

    (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

  • Health Canada Approves BALVERSA

    By Tawny Barratt | Comments are Closed

    In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

  • Bladder Cancer Canada receives Charity Intelligence 4-star ranking

    By Tawny Barratt | Comments are Closed

    Bladder Cancer Canada was recently reviewed by Charity Intelligence, an independent organization that researches Canadian charities so that donors can be well informed and give intelligently.  Of the 750 charities that Charity Intelligence has reviewed,Read more

  • BCG (OncoTICE) Supply Update – March 9, 2020

    By Tawny Barratt | Comments are Closed

    IMPORTANT UPDATE – March 9, 2020 Bladder Cancer Canada (BCC) and its Medical Advisory Board were advised by Merck Canada in November 2019 that they would continue to face challenges in the supply of the TICERead more

  • Support starts at home for the 12,000 Canadians who will be diagnosed with bladder cancer this year

    By Tawny Barratt | Comments are Closed

    TORONTO, CANADA (May 15, 2020) – This year, 12,000 Canadians will be diagnosed with bladder cancer, and for many of these Canadians, the global development of COVID-19 will impact bladder cancer diagnoses, treatments and outcomes.Read more

  • WEBINAR: Bladder Cancer Clinical Trials – What patients and caregivers should know (July 2020)

    By Tawny Barratt | Comments are Closed

    Posted July 30, 2020. Watch Webinar In this webinar, Dr. Girish Kulkarni set a foundation of the basics of clinical trials (what they are, how are they designed, terminology, etc.).  He then delved deeper into aspectsRead more

  • In memory of our dear friend, Paul Unterman

    By Tawny Barratt | Comments are Closed

    Many of us at Bladder Cancer Canada are saddened by the news of the recent passing of Paul Unterman, a volunteer and former board member, to bladder cancer. Paul volunteered on the board of directorsRead more

  • Robert Purves Receives BCC Founder’s Award

    By Tawny Barratt | Comments are Closed

    At a recent Board of Director’s meeting, and on behalf of the board and the Medical Advisory and Research Boards, BCC chair Ferg Devins was pleased to present the Founders’ Award to his friend andRead more

  • This year, support starts at home, says Dr. Dionne Duncan, of BCC Walk

    By Tawny Barratt | Comments are Closed

    We met up with our Executive Director Dr. Dionne Duncan and her good friend Mel on the waterfront in beautiful Port Credit, Ontario. Dionne and Mel demonstrate how we can support each other this SeptemberRead more

  • Our February newsletter is now available!

    By Tawny Barratt | Comments are Closed

    Our February newsletter shows how awareness efforts help save lives. Read newsletter Newsletter Highlight: What to know about BCG treatments, COVID-19 and the vaccine We recently collaborated with members of our Medical Advisory Board toRead more

  • BLADDER CANCER CANADA EXECUTIVE LEADERSHIP

    By Tawny Barratt | Comments are Closed

    The Board of Directors of Bladder Cancer Canada wishes to advise of a recent change in the leadership at Bladder Cancer Canada. Effective August 7th, 2020, Dr. Dionne Duncan is no longer in the employRead more

  • WHY I WALK – MESSAGE FROM CO-FOUNDER DAVID GUTTMAN

    By Tawny Barratt | Comments are Closed

    It is hard to believe, but it is once again time for our Bladder Cancer Awareness Walk, and due to the precautions that we are taking because of COVID -19, the walk will be virtual this year. Over the pastRead more

NextPrevious

Recent Posts

  • Bladder Cancer Canada (BCC) is seeking an Executive Director for our national charity.
  • The language of bladder cancer and how I’ve come to understand it
  • Congratulations to Dr. Michael A.S. Jewett for his appointment to the Order of Canada
  • Surviving the holidays as a caregiver
  • What is a blog and who the heck are we?

Archives

  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • December 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • November 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • August 2017
  • July 2017
  • June 2017
  • April 2017

Categories

  • Blog
  • Honouring our volunteers
  • Latest news and stories
  • Uncategorized
  • Upcoming meeting and events

    SUBSCRIBE TO OUR E-NEWSLETTER

    *Indicates required fields
    I agree to receive Bladder Cancer Canada's n e-newsletter containing news and updates. You can withdraw your subscription at any time.
    captcha

    GET IN TOUCH

    Address

    4936 Yonge Street
    Suite 1000
    Toronto, ON M2N 6S3

    Charitable Reg No.

    83612 6060 RR0001

    Phone
    1-866-674-8889
    Email & Media Contact

    info@bladdercancercanada.org

    SEND US A MESSAGE
    • Privacy Policy
    • Discussion Forum
    • Contact Us
    • Donate Now
    • ABOUT US
      • Our Mission/Vision
      • Board Of Directors
      • Medical Advisory
        and Research Board
      • Sponsors & Partners
      • Financial Statements
      • Contact Us
    • FACING
      BLADDER CANCER
      • Newly Diagnosed?
      • Canadian Patient Guidebooks
      • Dealing With Emotions
      • Get Support
      • Join a Discussion Forum
      • Videos
      • Webinar Recordings
      • Patient Resources
    • HELPFUL
      INFORMATION
      • Bladder Cancer Facts
      • See Red?
      • Symptoms
      • Bladder Cancer Basics
        • How The Body Works
        • Types of Bladder Cancer
        • Causes
        • Diagnosis
        • Staging and Grading
      • How will my cancer be treated?
        • Nonmuscle Invasive
        • Muscle Invasive
        • Bladder Preservation
        • Metastatic Bladder Cancer
      • Bladder Removal
        • Diversion Types
        • Common Issues
        • Chemotherapy
        • After Your Surgery
        • At Home
      • Upper Tract Urothelial Carcinoma
      • Palliative Care
      • Doctor Resources
      • Glossary
      • Links
    • STORIES,
      NEWS & EVENTS
      • Latest News & Stories
      • Upcoming Meetings And Events
      • Newsletter Archive
    • RESEARCH and
      CLINICAL TRIALS
      • Canadian Bladder Cancer Information System
      • Clinical Trials
      • BCC Funded Research
      • BCC Research Grant
    • GET
      INVOLVED
      • BC Awareness Month & 10-yr Anniversary
      • Volunteer
      • Join An Awareness Walk
      • Host A Fundraiser
      • Subscribe To Our Newsletter
    • DONATE NOW
      • General Donations
      • Honour & Memorial Donations
      • Join an Awareness Walk
      • Planned Giving
      • Employer Matching Gifts
      • Donate a Vehicle
      • Where Your Donations Go
    Bladder Cancer Canada